139 related articles for article (PubMed ID: 8819504)
41. Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells.
Gessi S; Varani K; Merighi S; Morelli A; Ferrari D; Leung E; Baraldi PG; Spalluto G; Borea PA
Br J Pharmacol; 2001 Sep; 134(1):116-26. PubMed ID: 11522603
[TBL] [Abstract][Full Text] [Related]
42. 125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor.
Palmer TM; Poucher SM; Jacobson KA; Stiles GL
Mol Pharmacol; 1995 Dec; 48(6):970-4. PubMed ID: 8848012
[TBL] [Abstract][Full Text] [Related]
43. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain.
Geary WA; Wooten GF
J Pharmacol Exp Ther; 1983 Apr; 225(1):234-40. PubMed ID: 6300375
[TBL] [Abstract][Full Text] [Related]
44. Characterization of the binding of a novel nonxanthine adenosine antagonist radioligand, [3H]CGS 15943, to multiple affinity states of the adenosine A1 receptor in the rat cortex.
Jarvis MF; Williams M; Do UH; Sills MA
Mol Pharmacol; 1991 Jan; 39(1):49-54. PubMed ID: 1987452
[TBL] [Abstract][Full Text] [Related]
45. 7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.
Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Monopoli A; Ongini E; Varani K; Borea PA
J Med Chem; 2002 Jan; 45(1):115-26. PubMed ID: 11754583
[TBL] [Abstract][Full Text] [Related]
46. Binding of [3H]MSX-2 (3-(3-hydroxypropyl)-7-methyl-8-(m-methoxystyryl)-1-propargylxanthine) to rat striatal membranes--a new, selective antagonist radioligand for A(2A) adenosine receptors.
Müller CE; Maurinsh J; Sauer R
Eur J Pharm Sci; 2000; 10(4):259-65. PubMed ID: 10838015
[TBL] [Abstract][Full Text] [Related]
47. Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors.
Ji XD; Jacobson KA
Drug Des Discov; 1999 Nov; 16(3):217-26. PubMed ID: 10624567
[TBL] [Abstract][Full Text] [Related]
48. Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists.
Baraldi PG; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Romagnoli R; Moorman AR; Varani K; Borea PA; Preti D
Bioorg Med Chem; 2012 Jan; 20(2):1046-59. PubMed ID: 22204739
[TBL] [Abstract][Full Text] [Related]
49. Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus.
Lillrank SM; Lipska BK; Weinberger DR; Fredholm BB; Fuxe K; Ferré S
Neurochem Int; 1999 Mar; 34(3):235-44. PubMed ID: 10355490
[TBL] [Abstract][Full Text] [Related]
50. Effect of SR 27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes.
Herbert JM; Laplace MC; Cailleau C; Maffrand JP
J Lipid Mediat; 1993 May; 7(1):57-78. PubMed ID: 8395255
[TBL] [Abstract][Full Text] [Related]
51. Characterization of adenosine A2 receptors in bovine retinal pigment epithelial membranes.
Blazynski C
Exp Eye Res; 1993 May; 56(5):595-9. PubMed ID: 8500568
[TBL] [Abstract][Full Text] [Related]
52. The selective adenosine A2A receptor antagonist SCH 58261 discriminates between two different binding sites for [3H]-CGS 21680 in the rat brain.
Lindström K; Ongini E; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):539-41. PubMed ID: 8897460
[TBL] [Abstract][Full Text] [Related]
53. Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects.
Varani K; Portaluppi F; Gessi S; Merighi S; Ongini E; Belardinelli L; Borea PA
Circulation; 2000 Jul; 102(3):285-9. PubMed ID: 10899090
[TBL] [Abstract][Full Text] [Related]
54. SCH 58261 differentially influences quinolinic acid-induced effects in striatal and in hippocampal slices.
Tebano MT; Domenici MR; Popoli P
Eur J Pharmacol; 2002 Aug; 450(3):253-7. PubMed ID: 12208317
[TBL] [Abstract][Full Text] [Related]
55. Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype.
Kim YC; Ji XD; Jacobson KA
J Med Chem; 1996 Oct; 39(21):4142-8. PubMed ID: 8863790
[TBL] [Abstract][Full Text] [Related]
56. Further characterization of a CNS adenosine A2a receptor ligand [11C]KF18446 with in vitro autoradiography and in vivo tissue uptake.
Ishiwata K; Ogi N; Shimada J; Nonaka H; Tanaka A; Suzuki F; Senda M
Ann Nucl Med; 2000 Apr; 14(2):81-9. PubMed ID: 10830524
[TBL] [Abstract][Full Text] [Related]
57. A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study.
Gessi S; Varani K; Merighi S; Cattabriga E; Iannotta V; Leung E; Baraldi PG; Borea PA
Mol Pharmacol; 2002 Feb; 61(2):415-24. PubMed ID: 11809867
[TBL] [Abstract][Full Text] [Related]
58. Glutamate residues in the second extracellular loop of the human A2a adenosine receptor are required for ligand recognition.
Kim J; Jiang Q; Glashofer M; Yehle S; Wess J; Jacobson KA
Mol Pharmacol; 1996 Apr; 49(4):683-91. PubMed ID: 8609897
[TBL] [Abstract][Full Text] [Related]
59. Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors.
Varani K; Cacciari B; Baraldi PG; Dionisotti S; Ongini E; Borea PA
Life Sci; 1998; 63(5):PL 81-7. PubMed ID: 9714428
[TBL] [Abstract][Full Text] [Related]
60. The cluster-arranged cooperative model: a model that accounts for the kinetics of binding to A1 adenosine receptors.
Franco R; Casadó V; Ciruela F; Mallol J; Lluis C; Canela EI
Biochemistry; 1996 Mar; 35(9):3007-15. PubMed ID: 8608139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
